Galimedix Therapeutics to present promising pre-clinical data with next generation oral amyloid beta aggregation modulator at AD/PDTM 2026 Conference
PUBLISHED Thursday, March 5, 2026 · galimedix therapeutics, inc.
AI BRIEFING
- ⬤ Galimedix Therapeutics to present promising pre-clinical data with next generation oral amyloid beta aggregation modulator at AD/PDTM 2026 Conference
- ⬤ Kensington, MD, USA and Munich/Martinsried, Germany
- ⬤ GLOBE NEWSWIRE
ADVERTISEMENT